These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17393610)

  • 21. [Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics].
    Dulícek P; Penka M; Binder T; Unzeitig V
    Vnitr Lek; 2006 Mar; 52 Suppl 1():58-62. PubMed ID: 16637451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
    De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
    Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
    Ogunyemi D; Cuellar F; Ku W; Arkel Y
    Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, treatment, and prevention of venous thromboembolism in pregnancy.
    Marshall AL
    Postgrad Med; 2014 Nov; 126(7):25-34. PubMed ID: 25387211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
    Zotz RB; Gerhardt A; Scharf RE
    Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium.
    Nelson SM; Greer IA
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.
    De Stefano V; Rossi E; Za T; Leone G
    Semin Thromb Hemost; 2006 Nov; 32(8):767-80. PubMed ID: 17171589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited thrombophilia and pregnancy: the obstetric perspective.
    Bonnar J; Green R; Norris L
    Semin Thromb Hemost; 1998; 24 Suppl 1():49-53. PubMed ID: 9840692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombophilia and anticoagulation in pregnancy: indications, risks and management.
    Montavon C; Hoesli I; Holzgreve W; Tsakiris DA
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):685-96. PubMed ID: 19012185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for pregnancy associated venous thromboembolism.
    McColl MD; Ramsay JE; Tait RC; Walker ID; McCall F; Conkie JA; Carty MJ; Greer IA
    Thromb Haemost; 1997 Oct; 78(4):1183-8. PubMed ID: 9364982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
    Mazzarella CR; Del Bianco A; Pietropaolo F
    Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy].
    Zotz RB; Gerhardt A; Scharf RE
    Hamostaseologie; 2006 Jan; 26(1):63-71. PubMed ID: 16444326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.
    Croles FN; Nasserinejad K; Duvekot JJ; Kruip MJ; Meijer K; Leebeek FW
    BMJ; 2017 Oct; 359():j4452. PubMed ID: 29074563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.